Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men

scientific article published on 01 January 2000

Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-8703(00)90324-7
P698PubMed publication ID10618578

P2093author name stringS Dawson
M Ryan
J B McCormick
J L Third
W F Bremner
R B Sothern
B M Nemchausky
E L Kanabrocki
P Shirazi
J H Olwin
S Vahed
R Rothschild
E S Connors
P2860cites workA NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEMQ28191072
A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)Q28238157
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.Q35171679
Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37).Q35824074
Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).Q37351861
Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypesQ37357176
Lipoprotein (a). Heterogeneity and biological relevanceQ37853403
Lipoprotein disorders as related to atherosclerotic cardiovascular disease.Q40461814
Lipoprotein (a) and coronary heart disease.Q40479993
Kringle-dependent structural and functional polymorphism of apolipoprotein (a).Q40520624
A prospective study of lipoprotein(a) and the risk of myocardial infarctionQ41061586
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participantsQ41148759
Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart StudyQ41148799
Circadian variation in the frequency of sudden cardiac deathQ41477518
The effect of sex, deviation from ideal weight and sampling time on blood constituents in presumably healthy subjectsQ41550011
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarctionQ43603017
Wind-chill and the seasonal variation of cerebrovascular diseaseQ43672231
Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patientsQ43788568
Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa studyQ43953541
Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with Prinzmetal angina in men.Q44122535
Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery diseaseQ44544121
Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarctionQ44654820
Weekly and yearly rhythms in plasma fibrinogen in hospitalized male military veteransQ45335725
Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer.Q52069012
Fibrinogen and risk of cardiovascular disease. The Framingham Study.Q52588834
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Q52626803
Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma.Q54397021
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.Q55060856
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).Q55066907
The Effects of Time of Venipuncture on Variation of Serum Constituents: Consideration of Within-day and Day-to-day Changes in a Group of Healthy Young MenQ67428626
Circadian variations of platelet aggregability and fibrinolytic activity in healthy subjectsQ67917616
Circadian variation in platelet function in healthy volunteersQ68053894
Predictive value of apolipoproteins in a prospective survey of coronary artery disease in menQ68125221
Lipoprotein(a). A unique risk factor for atherothrombotic diseaseQ68428387
Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteinsQ68614997
Day-by-day variation in fibrinolytic activity and in mortality from ischaemic heart diseaseQ68681809
Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study populationQ69413853
Circadian variation of transient myocardial ischemia in patients with coronary artery diseaseQ69717894
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarctionQ69992538
Lipoprotein(a) as a strong indicator for cerebrovascular diseaseQ70013947
Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of lifeQ70297064
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeQ70401843
Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activationQ70689573
Daily peaks in the incidence of sudden cardiac death and fatal stroke in Niigata PrefectureQ71309377
Fibrinogen as a risk factor for stroke and myocardial infarctionQ71438059
Lipoprotein Lp(a) and the risk for myocardial infarctionQ71505122
Lipoprotein(a) and risk of myocardial infarctionQ72349348
Further commentary: physiological parameters in laboratory animals and humansQ72380215
P433issue1 Pt 1
P407language of work or nameEnglishQ1860
P304page(s)164-173
P577publication date2000-01-01
P1433published inAmerican Heart JournalQ2227156
P1476titleRelation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men
P478volume139

Reverse relations

cites work (P2860)
Q43787052A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study
Q47167987Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study
Q33765425Circadian clocks and vascular function
Q54030374Circadian rhythm of serum total homocysteine in men.
Q34021701Circadian rhythms: from basic mechanisms to the intensive care unit
Q77120568Diurnal rhythms and hemostatic factors in atrial fibrillation
Q77060562Effect of marathon running on inflammatory and hemostatic markers
Q35672772Exploration of oxidative stress and inflammatory markers in relation to urinary phthalate metabolites: NHANES 1999-2006.
Q35502844Exposure to welding fumes is associated with acute systemic inflammatory responses
Q33877614Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver
Q35773666Long-term acute care patients weaning from prolonged mechanical ventilation maintain circadian rhythm
Q84430715Minor diurnal and activity-induced variations in daytime peripheral blood platelet counts do not have any major impact on platelet yield by platelet apheresis
Q34764789Post-prandial rise of microvesicles in peripheral blood of healthy human donors
Q44010602The influence of regular walking at different times of day on blood lipids and inflammatory markers in sedentary patients with coronary artery disease
Q28080493Therapeutic applications of circadian rhythms for the cardiovascular system
Q89482691Wake-up stroke and CT perfusion: effectiveness and safety of reperfusion therapy
Q34031098Wake-up stroke and stroke of unknown onset: a critical review
Q26796464What to do With Wake-Up Stroke
Q46883072When the Clock stops ticking, metabolic syndrome explodes